by Expert GSK pulls out of $20 billion race for Pfizer consumer assets 
LONDON (Reuters) – GlaxoSmithKline has quit the race to buy Pfizer’s consumer healthcare business, endangering an auction the U.S. drugmaker hoped would bring in as much as $20 billion. Share this: